Los Angeles, CA -- (SBWIRE) -- 04/12/2019 -- A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields. Neurology disorders are affecting major percentage of the global population and it is considered a major cause of disability around the globe. The prevalence of neurological disorders is growing at a very high pace, in which biomarkers are expected play a vital role in better understanding of the disease and development of personalized medicine specific to the patient.
North Amercian was the leading market in 2017, and is expected to continue this trend throughout the forecast period. This is attributed to rise in expenditure on the management of Parkinson's disease in the country. As of 2017, North Amercian had a population of 326,506,644 individuals, and about 60,000 individuals are diagnosed with Parkinson's diseases every year. Thus, significant prevalence of this disease among the North Amercian population drives the growth of the market. However, China is projected to emerge as a lucrative market in future, due to the higher prevalence of Parkinson's disease observed in males in 2017.
Get PDF template of this report: https://www.qyresearch.com/sample-form/form/1092883/global-neurological-biomarkers-market
In 2018, the global Neurological Biomarkers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2019 and 2025.
This report studies the Neurological Biomarkers market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
Quanterix
Myriad RBM
QIAGEN
ADx NeuroSciences
Merck
Euroimmun
Thermo Fisher
BioCrypton
ACOBIOM
Banyan Biomarkers
Olink Biosciences
BioAgilytix
Abbott Laboratories
Proteome Sciences
Athena Diagnostics
Psynova Neurotech
Bio-Rad Laboratories
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Genomics Biomarker
Proteomics Biomarker
Metabolomics Biomarkers
Imaging Biomarkers
Others
Market segment by Application, the market can be split into
Research Organizations, Pharma & Biotech Companies
Clinical Diagnostics
Get Full Report Now at USD 3,550 @ https://www.qyresearch.com/settlement/pre/ae581ddda1f5e3eec68b2a704beb205c,0,1,Global%20Neurological%20Biomarkers%20Market%20Report,%20History%20and%20Forecast%202014-2025,%20Breakdown%20Data%20by%20Companies,%20Key%20Regions,%20Types%20and%20Application
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in the consulting industry.